172 related articles for article (PubMed ID: 33782863)
21. Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo.
Watchon M; Luu L; Robinson KJ; Yuan KC; De Luca A; Suddull HJ; Tym MC; Guillemin GJ; Cole NJ; Nicholson GA; Chung RS; Lee A; Laird AS
Mol Brain; 2021 Aug; 14(1):128. PubMed ID: 34416891
[TBL] [Abstract][Full Text] [Related]
22. ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease.
Vasconcelos-Ferreira A; Martins IM; Lobo D; Pereira D; Lopes MM; Faro R; Lopes SM; Verbeek D; Schmidt T; Nóbrega C; Pereira de Almeida L
Mol Ther; 2022 Jan; 30(1):370-387. PubMed ID: 34298131
[TBL] [Abstract][Full Text] [Related]
23. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
[TBL] [Abstract][Full Text] [Related]
24. Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB.
Parra-Millán R; Guerrero-Gómez D; Ayerbe-Algaba R; Pachón-Ibáñez ME; Miranda-Vizuete A; Pachón J; Smani Y
mSphere; 2018; 3(2):. PubMed ID: 29600279
[TBL] [Abstract][Full Text] [Related]
25. A high glucose diet induces autophagy in a HLH-30/TFEB-dependent manner and impairs the normal lifespan of
Franco-Juárez B; Mejía-Martínez F; Moreno-Arriola E; Hernández-Vázquez A; Gómez-Manzo S; Marcial-Quino J; Arreguín-Espinosa R; Velázquez-Arellano A; Ortega-Cuellar D
Aging (Albany NY); 2018 Oct; 10(10):2657-2667. PubMed ID: 30299269
[TBL] [Abstract][Full Text] [Related]
26. A conserved cysteine-based redox mechanism sustains TFEB/HLH-30 activity under persistent stress.
Martina JA; Guerrero-Gómez D; Gómez-Orte E; Antonio Bárcena J; Cabello J; Miranda-Vizuete A; Puertollano R
EMBO J; 2021 Feb; 40(3):e105793. PubMed ID: 33314217
[TBL] [Abstract][Full Text] [Related]
27. The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.
Vasconcelos-Ferreira A; Carmo-Silva S; Codêsso JM; Silva P; Martinez ARM; França MC; Nóbrega C; Pereira de Almeida L
Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12763. PubMed ID: 34432315
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons.
Li YX; Sibon OCM; Dijkers PF
J Neuroinflammation; 2018 Sep; 15(1):261. PubMed ID: 30205834
[TBL] [Abstract][Full Text] [Related]
29. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
[TBL] [Abstract][Full Text] [Related]
30. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
31. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
32. Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.
Costa MDC; Ashraf NS; Fischer S; Yang Y; Schapka E; Joshi G; McQuade TJ; Dharia RM; Dulchavsky M; Ouyang M; Cook D; Sun D; Larsen MJ; Gestwicki JE; Todi SV; Ivanova MI; Paulson HL
Brain; 2016 Nov; 139(11):2891-2908. PubMed ID: 27645800
[TBL] [Abstract][Full Text] [Related]
33. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
[TBL] [Abstract][Full Text] [Related]
35. Planning Future Clinical Trials for Machado-Joseph Disease.
Saute JAM; Jardim LB
Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
[TBL] [Abstract][Full Text] [Related]
36. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
37. Host-commensal interaction promotes health and lifespan in
Dinić M; Herholz M; Kačarević U; Radojević D; Novović K; Đokić J; Trifunović A; Golić N
Aging (Albany NY); 2021 Mar; 13(6):8040-8054. PubMed ID: 33770762
[TBL] [Abstract][Full Text] [Related]
38. Genetic Variation in ATXN3 (Ataxin-3) 3'UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3.
Melo ARV; Raposo M; Ventura M; Martins S; Pavão S; Alonso I; Bettencourt C; Lima M
Cerebellum; 2023 Feb; 22(1):37-45. PubMed ID: 35034258
[TBL] [Abstract][Full Text] [Related]
39. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Mergener R; Furtado GV; de Mattos EP; Leotti VB; Jardim LB; Saraiva-Pereira ML
Neuromolecular Med; 2020 Mar; 22(1):133-138. PubMed ID: 31587151
[TBL] [Abstract][Full Text] [Related]
40. Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
McLoughlin HS; Moore LR; Chopra R; Komlo R; McKenzie M; Blumenstein KG; Zhao H; Kordasiewicz HB; Shakkottai VG; Paulson HL
Ann Neurol; 2018 Jul; 84(1):64-77. PubMed ID: 29908063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
